'Winners' and 'Losers'; Mandated Sick Leave and Cancer Screening; More AI Advances

[MEDPAGE TODAY]( Oncology Update Friday, March 03, 2023 ['Winners' and 'Losers'; Mandated Sick Leave and Cancer Screening; More AI Advances]( ['Alarming' Rise in Colon Cancer Rates Among Younger People]( [Possible Role for Ipilimumab in Metastatic Bladder Cancer, Study Suggests]( [Cancer-Free Medicare Recipients Received Fentanyl Indicated for Cancer Pain]( [Duran Duran's Andy Taylor's Prostate Cancer]( ADVERTISEMENT Exclusives & Features [Stella Immanuel Highest U.S. Prescriber of Ivermectin and HCQ]( [Expanding ICD Codes May Aid Rare Disease Patients, Research]( [Star Surgeon, UPMC Will Pay $8.5M to Settle Concurrent Surgeries Lawsuit]( [Prostate-Specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death.]( PURPOSE: Both the performance characteristics of prostate-specific membrane antigen positron emission tomography and insurance approval improves with increasing prostate-specific antigen (PSA) level... [READ MORE]( [A Single-cell Atlas Identifies Pretreatment Features of Primary Imatinib Resistance in Chronic Myeloid Leukemia.]( Primary resistance to tyrosine kinase inhibitors (TKI) is a significant barrier to optimal outcomes in chronic myeloid leukemia, but little is known about the factors contributing to response... [READ MORE]( [Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label study.]( BACKGROUND: In the primary analysis of the CLEAR study, lenvatinib plus pembrolizumab significantly improved progression-free survival and overall survival versus sunitinib in patients with advanced... [READ MORE]( [The role of ubiquitin pathway-mediated regulation of immune checkpoints in cancer immunotherapy.]( With the continuous cognition of the relationship between tumor cells and tumor immune microenvironment, immunotherapy based on the immune checkpoint blockade has achieved great breakthroughs, led to... [READ MORE]( [Moving Forward Liquid Biopsy in Early Liver Cancer Detection.]( Early cancer detection is an attractive and promising application for liquid biopsy that might revolutionize cancer screenings. In this issue of Cancer Discovery, Foda and colleagues expand the... [READ MORE]( [A Property of Everyday Health group]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Spec_Oncology_Update?xid=nl_mpt_Oncology_update_2023-03-03&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011